drugset / Trial / NCT06257212

Live Vaccines and Innate Immune Training in COPD.

NCT06257212

Phase 4 Completed 60 enrolled Josefin Eklöf
RandomizedSingle-groupSingle-blindTreatment

Summary

A randomized, single-blinded clinical pilot study to assess whether vaccination with live attenuated vaccines can induce trained immunity and cause beneficial changes in patients with COPD.

Timeline

Start
2024-02-28
Primary completion
2025-08-25
Completion
2025-08-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator BCG vaccine (Danish strain 1331) Unknown 0.1 ml Other
Comparator MMR vaccine Vaccine 0.5 ml Subcutaneous